yth2206游艇会
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.04.29
关于公司会计政策变更的公告
2019.04.29
中天国富有限公司关于公司2018年度募集资金存放与使用情况的专项核查意见
2019.04.29
2018年度财务决算报告
2019.04.29
关于公司募集资金年度存放与实际使用情况的鉴证报告
2019.04.29
关于深圳市多普乐实业发展有限公司2018年度业绩承诺完成情况的说明
2019.04.29
上市公司内部控制规则落实自查表
2019.04.24
关于2019年非公开发行公司债券发行结果的公告
2019.04.19
关于控股子公司新药临床试验申请获得受理的公告
2019.04.08
关于注销部分募集资金专户的公告
2019.03.30
2019年度第一季度业绩预告
第一页
上一页
49
50
51
52
53
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.